NCT02669823View on ClinicalTrials.gov

Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region

CompletedOBSERVATIONAL
Enrollment

930

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Tropical Infectious Diseases
Interventions
OTHER

None, treatment as actual best practice

Trial Locations (1)

218 Ouaga 11

Clinical Research Unit Nanaro, Nanaro

All Listed Sponsors
collaborator

Clinical Research Unit of Nanaro (CRUN), Burkina Faso

UNKNOWN

collaborator

Instituut voor Tropische Geneeskunde (ITG), Belgium

UNKNOWN

collaborator

Radboud University Medical Center

OTHER

lead

Sysmex Europe GmbH

INDUSTRY

NCT02669823 - Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region | Biotech Hunter | Biotech Hunter